Skip to content

Clinical trials

Enrolling by invitation Phase 3 trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 3 Status: Enrolling by invitation Country / region: Brazil Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20191
20212
20224
20233
20247
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Enrolling by invitation22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen2
Sanofi2
Viatris Innovation GmbH2
ACADIA Pharmaceuticals Inc.1
Alkermes, Inc.1
Alnylam Pharmaceuticals1
AstraZeneca1
Astria Therapeutics, Inc.1
Cristiane Decat Bergerot, PhD1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Connective Tissue Diseases3
Amyloidosis2
Angioedemas, Hereditary2
Epilepsy2
Immune System Diseases2
Lupus Erythematosus, Systemic2
Neoplasms2
Seizures2
Angioedema1
Asthma1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.